{"id":391,"date":"2018-11-13T12:52:42","date_gmt":"2018-11-13T03:52:42","guid":{"rendered":"http:\/\/osaka-ohtani-clinpharm.com\/blogWP\/?page_id=391"},"modified":"2022-02-04T15:38:18","modified_gmt":"2022-02-04T06:38:18","slug":"2017%e5%b9%b4","status":"publish","type":"page","link":"http:\/\/osaka-ohtani-clinpharm.com\/blogWP\/%e6%a5%ad%e7%b8%be\/2017%e5%b9%b4\/","title":{"rendered":"2017\u5e74"},"content":{"rendered":"<h1>2017\u5e74<\/h1>\n<h1>\u539f\u8457\u8ad6\u6587<\/h1>\n<ul>\n<li>Hirotani Y*, Fukamachi J, Ueyama R, Urashima Y and Ikeda K: ffects of Capsaicin Coadministered with Eicosapentaenoic Acid on Obesity-Related Dysregulation in High-Fat-Fed Mice. Biol. Pharm. Bull. 40(9): 1584-1585,2017<\/li>\n<li><span style=\"font-size: 14.08px;\">Ueda M*, Harada K, Ikeda K, Ohishi M, Kitamura M, Ueda H, Azenishi K, Inatsuki S, Niki K, Okajima C\uff0cTempaku M\uff0cFukuda Y\uff0cYoshida S\uff0cHirata K, Suna S, Kataoka K, Kogo M and Uejima E: harmacokinetics of Loxoprofen and Cefcapene following Single Combined Dose Dosing in Health Volunteers at before, during or immediately after 120 min Enteral Tube Feeding of 400 mL ENSURE LIQUID<sup>\u00ae<\/sup>. Jpn. J. Clin. Pharmacol. Ther. 48(6): 185-193,2017<\/span><\/li>\n<\/ul>\n<h1>\u5b66\u4f1a\u767a\u8868<\/h1>\n<ul>\n<li>\u4e09\u6d66\u7531\u5948\u3001\u5ee3\u8c37\u82b3\u5f66\u3001\u6d66\u5d8b\u5eb8\u5b50\u3001\u6c60\u7530\u8ce2\u4e8c.&nbsp; \u5e02\u6c11\u5927\u5b66\u9023\u643a\u8b1b\u5ea7\u5f8c\u306e\u30bb\u30eb\u30d5\u30e1\u30c7\u30a3 \u30b1\u30fc\u30b7\u30e7\u30f3\u884c\u52d5\u3068OTC\u533b\u85ac\u54c1\u306b\u95a2\u3059\u308b\u610f\u8b58\u8abf\u67fb. \u65e5\u672c\u793e\u4f1a\u85ac\u5b66\u4f1a\u7b2c\uff13\uff16\u5e74\u4f1a\uff08\u5927\u962a\uff09, 2017<\/li>\n<li>\u5ee3\u8c37\u82b3\u5f66\uff0c\u5c3e\u5d0e \u671b\uff0c\u8fbb\u3000\u7965\u5f18\uff0c\u6d66\u5d8b\u5eb8\u5b50\uff0c\u6c60\u7530\u8ce2\u4e8c .&nbsp; Eicosapentaenoic acid \u6295\u4e0e\u306b\u3088\u308b\u9ad8\u8102\u80aa\u98df\u8a98\u767a\u80a5\u6e80\u30e2\u30c7\u30eb\u30de\u30a6\u30b9\u306b\u5bfe\u3059\u308b\u809d\u969c\u5bb3\u4fee\u5fa9\u52b9\u679c\u306e\u691c\u8a0e, \u7b2c38\u56de\u65e5\u672c\u80a5\u6e80\u5b66\u4f1a\uff08\u5927\u962a\uff09, 2017<\/li>\n<li>\u5ee3\u8c37\u82b3\u5f66\u3001\u5ddd\u53e3\u3000\u8389\u83dc\u3001\u5ca1\u672c\u77e5\u4f73\u3001\u5927\u7af9\u7531\u8d77\u3001\u5ddd\u9808\u3000\u83d6\u3001\u6d66\u5d8b\u5eb8\u5b50\u3001\u6c60\u7530\u8ce2\u4e8c.&nbsp; \u85ac\u5b66\u751f\u306b\u5bfe\u3059\u308b\u8a8d\u77e5\u75c7\u30b5\u30dd\u30fc\u30bf\u30fc\u990a\u6210\u8b1b\u5ea7\u5b9f\u65bd\u5f8c\u306e\u8a8d\u77e5\u75c7\u60a3\u8005\u306b\u5bfe\u3059\u308b\u610f\u8b58\u8abf\u67fb, \u65e5\u672c\u793e\u4f1a\u85ac\u5b66\u4f1a\u7b2c\uff13\uff16\u5e74\u4f1a\uff08\u5927\u962a\uff09, 2017<\/li>\n<li>\u6d66\u5d8b\u3000\u5eb8\u5b50\u3001\u6728\u66fd\u3000\u611b\u7f8e\u3001\u6c60\u7530\u3000\u8ce2\u4e8c\u3001\u9ad8\u7530\u3000\u5b8f\u6587\u3001\u91ce\u4e95\u3000\u4e9c\u6c99\u7f8e\u3001\u5357\u6a4b\u3000\u85ab\u3001\u5ee3\u8c37\u3000\u82b3\u5f66.&nbsp; Phenytoin\u3001Fosphenytoin\u3001\u304a\u3088\u3073phenytoin\u4e3b\u4ee3\u8b1d\u7269\u306eHPLC\u540c\u6642\u6e2c\u5b9a\u6cd5\u306e\u78ba\u7acb, \u7b2c34\u56de\u65e5\u672cTDM\u5b66\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a, 2017<\/li>\n<li>\u5ee3\u8c37\u82b3\u5f66\u3001\u5ca1\u672c\u77e5\u4f73\u3001\u5927\u7af9\u7531\u8d77\u3001\u5ddd\u9808\u3000\u83d6\u3001\u5ddd\u53e3\u8389\u83dc\u3001\u6d66\u5d8b\u5eb8\u5b50\u3001\u6c60\u7530\u8ce2\u4e8c.&nbsp; P\u5730\u57df\u4f4f\u6c11\u3092\u5bfe\u8c61\u3068\u3057\u305f\u7cd6\u5c3f\u75c5\u306b\u5bfe\u3059\u308b\u610f\u8b58\u8abf\u67fb\u3068HbA1c\u6e2c\u5b9a\u30c1\u30a7\u30c3\u30af\u306e\u610f\u7fa9\u306b\u95a2\u3059\u308b\u691c\u8a0e, \u7b2c24\u56de\u65e5\u672c\u672a\u75c5\u30b7\u30b9\u30c6\u30e0\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\uff08\u6a2a\u6d5c\uff09, 2017<\/li>\n<li>\u5ee3\u8c37\u82b3\u5f66\u3001\u5ca1\u672c\u77e5\u4f73\u3001\u5927\u7af9\u7531\u8d77\u3001\u5ddd\u9808\u3000\u83d6\u3001\u5ddd\u53e3\u8389\u83dc\u3001\u6d66\u5d8b\u5eb8\u5b50\u3001\u6c60\u7530\u8ce2\u4e8c.&nbsp; P\u5730\u57df\u4f4f\u6c11\u3092\u5bfe\u8c61\u3068\u3057\u305f\u7cd6\u5c3f\u75c5\u306b\u5bfe\u3059\u308b\u610f\u8b58\u8abf\u67fb\u3068HbA1c\u6e2c\u5b9a\u30c1\u30a7\u30c3\u30af\u306e\u610f\u7fa9\u306b\u95a2\u3059\u308b\u691c\u8a0e, \u7b2c24\u56de\u65e5\u672c\u672a\u75c5\u30b7\u30b9\u30c6\u30e0\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\uff08\u6a2a\u6d5c\uff09, 2017<\/li>\n<\/ul>\n<h1>\u8b1b\u6f14<\/h1>\n<ul>\n<li>\u5ee3\u8c37\u3000\u82b3\u5f66. \u30bb\u30eb\u30d5\u30e1\u30c7\u30a3\u30b1\u30fc\u30b7\u30e7\u30f3\u306e\u30b9\u30b9\u30e1\uff1a\u81ea\u3089\u53d6\u308a\u7d44\u3080\u751f\u6d3b\u7fd2\u6163\u75c5\u306e\u4e88\u9632\u3068\u6539\u5584\uff08\u30b7\u30cb\u30a2\u306e\u305f\u3081\u306e\u300c\u30bb\u30eb\u30d5\u30e1\u30c7\u30a3\u30b1\u30fc\u30b7\u30e7\u30f3\u300d\u30b5\u30dd\u30fc\u30c8\u8b1b\u5ea7\uff09, \u306f\u3073\u304d\u306e\u5e02\u6c11\u5927\u5b66\u5e73\u621029\u5e74\u5f8c\u671f\u8b1b\u5ea7, 2017<\/li>\n<li>Kenji Ikeda. <em>In vitro<\/em> approach for placental drug transport studies using induced pluripotent stem cells, 15th International Congress of Therapeutic Drug Monitoring &amp; Clinical Toxicology\u3000(IATDMCT), in Kyoto, 2017<\/li>\n<li>\u6c60\u7530\u3000\u8ce2\u4e8c. iPS\u7d30\u80de\u3092\u7528\u3044\u305fin vitro\u533b\u85ac\u54c1\u80ce\u5150\u79fb\u884c\u6027\u8a55\u4fa1\u7cfb\u306e\u69cb\u7bc9\u306b\u95a2\u3059\u308b\u691c\u8a0e, \u7b2c\uff13\uff18\u56de\u767d\u91d1\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0, 2017<\/li>\n<li>\u5ee3\u8c37\u3000\u82b3\u5f66. \u30bb\u30eb\u30d5\u30e1\u30c7\u30a3\u30b1\u30fc\u30b7\u30e7\u30f3 \u2015 \u77e5\u3063\u3066\u304a\u304d\u305f\u3044\u6b63\u3057\u3044\u85ac\u306e\u4f7f\u3044\u65b9, \u6cb3\u5185\u9577\u91ce\u5e02\u6c11\u5927\u5b66\u300c\u304f\u308d\u307e\u308d\u587e\u300d2016\uff08\u5e73\u621028\uff09\u5e74\u5ea6\u5f8c\u671f\u8b1b\u5ea7, 2017<\/li>\n<\/ul>\n<h1>\u53d7\u8cde<\/h1>\n<ul>\n<li>Kawasaki Y,&nbsp;Ikeda K, Matsuda H, Kishida S, Itokazu Y, Kiso M, Urashima Y and Hirotani Y. <em>In Vitro <\/em>Treatment of Induced Pluripotent Stem Cells with Retinoic Acid for the Placental Drug Transport Evaluation Model, 15th International Congress of Therapeutic Drug Monitoring &amp; Clinical Toxicology\u3000(IATDMCT), Kyoto, Japan, 2017 (Student Grant)<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"2017\u5e74 \u539f\u8457\u8ad6\u6587 Hirotani Y*, Fukamachi J, Ueyama R, Urashima Y and Ikeda K: ffects of Capsaicin Coadministered with &#8230;","protected":false},"author":1,"featured_media":0,"parent":39,"menu_order":19,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"http:\/\/osaka-ohtani-clinpharm.com\/blogWP\/wp-json\/wp\/v2\/pages\/391"}],"collection":[{"href":"http:\/\/osaka-ohtani-clinpharm.com\/blogWP\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/osaka-ohtani-clinpharm.com\/blogWP\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/osaka-ohtani-clinpharm.com\/blogWP\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/osaka-ohtani-clinpharm.com\/blogWP\/wp-json\/wp\/v2\/comments?post=391"}],"version-history":[{"count":2,"href":"http:\/\/osaka-ohtani-clinpharm.com\/blogWP\/wp-json\/wp\/v2\/pages\/391\/revisions"}],"predecessor-version":[{"id":541,"href":"http:\/\/osaka-ohtani-clinpharm.com\/blogWP\/wp-json\/wp\/v2\/pages\/391\/revisions\/541"}],"up":[{"embeddable":true,"href":"http:\/\/osaka-ohtani-clinpharm.com\/blogWP\/wp-json\/wp\/v2\/pages\/39"}],"wp:attachment":[{"href":"http:\/\/osaka-ohtani-clinpharm.com\/blogWP\/wp-json\/wp\/v2\/media?parent=391"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}